A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
Bio-Pharm Solutions Co., Ltd.
Start Date
March 26, 2020
End Date
December 31, 2021
Administered By
Pediatrics, Neurology
Awarded By
Bio-Pharm Solutions Co., Ltd.
Start Date
March 26, 2020
End Date
December 31, 2021